Global Japanese Encephalitis Virus Vaccine Market Research Report 2023

Publisher Name :
Date: 11-Oct-2023
No. of pages: 87
Inquire Before Buying

Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.

According to QYResearch's new survey, global Japanese Encephalitis Virus Vaccine market is projected to reach US$ 572.2 million in 2029, increasing from US$ 408.6 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Japanese Encephalitis Virus Vaccine market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Japanese Encephalitis Virus Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- Research Foundation for Microbial Diseases of Osaka University

- Valneva Austria GmbH

- Chengdu Institute

- Liaoning Dacheng

- Wuhan Institute

Segment by Type

- Inactivated Vaccine

- Live Attenuated Vaccine

Segment by Application

- Public

- Private

Consumption by Region

- North America

- - the United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

The Japanese Encephalitis Virus Vaccine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers' Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers' Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Global Japanese Encephalitis Virus Vaccine Market Research Report 2023

Table of Contents
1 Japanese Encephalitis Virus Vaccine Market Overview
1.1 Product Overview and Scope of Japanese Encephalitis Virus Vaccine
1.2 Japanese Encephalitis Virus Vaccine Segment by Type
1.2.1 Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Japanese Encephalitis Virus Vaccine Segment by Application
1.3.1 Global Japanese Encephalitis Virus Vaccine Market Value by Application: (2023-2029)
1.3.2 Public
1.3.3 Private
1.4 Global Japanese Encephalitis Virus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Japanese Encephalitis Virus Vaccine Revenue 2018-2029
1.4.2 Global Japanese Encephalitis Virus Vaccine Sales 2018-2029
1.4.3 Global Japanese Encephalitis Virus Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Japanese Encephalitis Virus Vaccine Market Competition by Manufacturers
2.1 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Japanese Encephalitis Virus Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Japanese Encephalitis Virus Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Type & Application
2.7 Japanese Encephalitis Virus Vaccine Market Competitive Situation and Trends
2.7.1 Japanese Encephalitis Virus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Japanese Encephalitis Virus Vaccine Players Market Share by Revenue
2.7.3 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Japanese Encephalitis Virus Vaccine Retrospective Market Scenario by Region
3.1 Global Japanese Encephalitis Virus Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Japanese Encephalitis Virus Vaccine Global Japanese Encephalitis Virus Vaccine Sales by Region: 2018-2029
3.2.1 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2018-2023
3.2.2 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2024-2029
3.3 Global Japanese Encephalitis Virus Vaccine Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2018-2029
3.3.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2018-2023
3.3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2024-2029
3.4 North America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.4.1 North America Japanese Encephalitis Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
3.4.3 North America Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.5.1 Europe Japanese Encephalitis Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
3.5.3 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Japanese Encephalitis Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2018-2029)
4.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Type (2018-2023)
4.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Type (2024-2029)
4.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2029)
4.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2023)
4.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type (2024-2029)
4.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Japanese Encephalitis Virus Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2018-2029)
5.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Application (2018-2023)
5.1.2 Global Japanese Encephalitis Virus Vaccine Sales by Application (2024-2029)
5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2029)
5.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2023)
5.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application (2024-2029)
5.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Japanese Encephalitis Virus Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Research Foundation for Microbial Diseases of Osaka University
6.1.1 Research Foundation for Microbial Diseases of Osaka University Corporation Information
6.1.2 Research Foundation for Microbial Diseases of Osaka University Description and Business Overview
6.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Portfolio
6.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments/Updates
6.2 Valneva Austria GmbH
6.2.1 Valneva Austria GmbH Corporation Information
6.2.2 Valneva Austria GmbH Description and Business Overview
6.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Portfolio
6.2.5 Valneva Austria GmbH Recent Developments/Updates
6.3 Chengdu Institute
6.3.1 Chengdu Institute Corporation Information
6.3.2 Chengdu Institute Description and Business Overview
6.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.3.5 Chengdu Institute Recent Developments/Updates
6.4 Liaoning Dacheng
6.4.1 Liaoning Dacheng Corporation Information
6.4.2 Liaoning Dacheng Description and Business Overview
6.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Portfolio
6.4.5 Liaoning Dacheng Recent Developments/Updates
6.5 Wuhan Institute
6.5.1 Wuhan Institute Corporation Information
6.5.2 Wuhan Institute Description and Business Overview
6.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Portfolio
6.5.5 Wuhan Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis
7.2 Japanese Encephalitis Virus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Japanese Encephalitis Virus Vaccine Production Mode & Process
7.4 Japanese Encephalitis Virus Vaccine Sales and Marketing
7.4.1 Japanese Encephalitis Virus Vaccine Sales Channels
7.4.2 Japanese Encephalitis Virus Vaccine Distributors
7.5 Japanese Encephalitis Virus Vaccine Customers
8 Japanese Encephalitis Virus Vaccine Market Dynamics
8.1 Japanese Encephalitis Virus Vaccine Industry Trends
8.2 Japanese Encephalitis Virus Vaccine Market Drivers
8.3 Japanese Encephalitis Virus Vaccine Market Challenges
8.4 Japanese Encephalitis Virus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Japanese Encephalitis Virus Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Japanese Encephalitis Virus Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Japanese Encephalitis Virus Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Japanese Encephalitis Virus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Japanese Encephalitis Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Virus Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Japanese Encephalitis Virus Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Japanese Encephalitis Virus Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Japanese Encephalitis Virus Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Japanese Encephalitis Virus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Japanese Encephalitis Virus Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Japanese Encephalitis Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Japanese Encephalitis Virus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2024-2029)
Table 60. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Japanese Encephalitis Virus Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Japanese Encephalitis Virus Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2024-2029)
Table 70. Research Foundation for Microbial Diseases of Osaka University Corporation Information
Table 71. Research Foundation for Microbial Diseases of Osaka University Description and Business Overview
Table 72. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product
Table 74. Research Foundation for Microbial Diseases of Osaka University Recent Developments/Updates
Table 75. Valneva Austria GmbH Corporation Information
Table 76. Valneva Austria GmbH Description and Business Overview
Table 77. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product
Table 79. Valneva Austria GmbH Recent Developments/Updates
Table 80. Chengdu Institute Corporation Information
Table 81. Chengdu Institute Description and Business Overview
Table 82. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Chengdu Institute Japanese Encephalitis Virus Vaccine Product
Table 84. Chengdu Institute Recent Developments/Updates
Table 85. Liaoning Dacheng Corporation Information
Table 86. Liaoning Dacheng Description and Business Overview
Table 87. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product
Table 89. Liaoning Dacheng Recent Developments/Updates
Table 90. Wuhan Institute Corporation Information
Table 91. Wuhan Institute Description and Business Overview
Table 92. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Wuhan Institute Japanese Encephalitis Virus Vaccine Product
Table 94. Wuhan Institute Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Japanese Encephalitis Virus Vaccine Distributors List
Table 98. Japanese Encephalitis Virus Vaccine Customers List
Table 99. Japanese Encephalitis Virus Vaccine Market Trends
Table 100. Japanese Encephalitis Virus Vaccine Market Drivers
Table 101. Japanese Encephalitis Virus Vaccine Market Challenges
Table 102. Japanese Encephalitis Virus Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Japanese Encephalitis Virus Vaccine
Figure 2. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Japanese Encephalitis Virus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Japanese Encephalitis Virus Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Japanese Encephalitis Virus Vaccine Market Share by Application in 2022 & 2029
Figure 8. Public
Figure 9. Private
Figure 10. Global Japanese Encephalitis Virus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Japanese Encephalitis Virus Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Japanese Encephalitis Virus Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Japanese Encephalitis Virus Vaccine Average Price (USD/Unit) & (2018-2029)
Figure 14. Japanese Encephalitis Virus Vaccine Report Years Considered
Figure 15. Japanese Encephalitis Virus Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Japanese Encephalitis Virus Vaccine Players: Market Share by Revenue in 2022
Figure 18. Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Japanese Encephalitis Virus Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. the United States Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. UK Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Japanese Encephalitis Virus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Japanese Encephalitis Virus Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Japanese Encephalitis Virus Vaccine by Type (2018-2029)
Figure 54. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Japanese Encephalitis Virus Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Japanese Encephalitis Virus Vaccine by Application (2018-2029)
Figure 57. Global Japanese Encephalitis Virus Vaccine Price (USD/Unit) by Application (2018-2029)
Figure 58. Japanese Encephalitis Virus Vaccine Value Chain
Figure 59. Japanese Encephalitis Virus Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs